Product Name
Bone Morphogenetic Protein Receptor 2 (BMPR2), Recombinant Protein
Full Product Name
Recombinant Bone Morphogenetic Protein Receptor 2 (BMPR2)
Product Gene Name
BMPR2 recombinant protein
[Similar Products]
Matching Pairs
Unconjugated
Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2013127)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
APC-CY7 Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035209)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
PE Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035210)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
APC Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035211)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
Cy3 Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035212)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
FITC Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035213)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
HRP Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2035214)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Matching Pairs
Biotin Conjugated Antibody: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2091317)
Immunogen: Bone Morphogenetic Protein Receptor 2 (BMPR2) (MBS2018213)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Sequence
The target protein is fused with two N-terminal Tags, His-tag and T7-tag, its sequence is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- SQNQ ERLCAFKDPY QQDLGIGESR ISHENGTILC SKGSTCYGLW EKSKGDINLV KQGCWSHIGD PQECHYEECV VTTTPPSIQN GTYRFCCCST DLCNVNFTEN FPPPDTTPLS PPHSFNRDET
Chromosome Location
Chromosome: 2; NC_000002.11 (203241033..203432474). Location: 2q33-q34
3D Structure
ModBase 3D Structure for Q13873
Purity/Purification
> 95%
Form/Format
Supplied as lyophilized form in PBS,pH7.4, containing 5% sucrose, 0.01% sarcosyl.
Organism
Homo sapiens (Human)
Expression System
Prokaryotic expression
Residues
Ser27~Thr150 (Accession # Q13873) with two N-terminal Tags, His-tag and T7-tag
Endotoxin Level
<1.0EU per 1ug (determined by the LAL method)
Reconstitution
Reconstitute in sterile PBS, pH7.2-pH7.4.
Preparation and Storage
Avoid repeated freeze/thaw cycles. Store at 2-8 degree C for one month. Aliquot and store at -80 degree C for 12 months.
Stability Test: The thermal stability is described by the loss rate of the targetprotein. The loss rate was determined by accelerated thermal degradation test,that is, incubate the protein at 37 degree C for 48h, and no obvious degradation andprecipitation were observed. (Referring from China Biological Products Standard,which was calculated by the Arrhenius equation.) The loss of this protein is lessthan 5% within the expiration date under appropriate storage condition.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of BMPR2 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
BMPR2 recombinant protein
About the Marker: Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at doubleintensity to make location and size approximation of proteins of interestquick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
Applications Tested/Suitable for BMPR2 recombinant protein
SDS-PAGE, Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP)
SDS-Page of BMPR2 recombinant protein
NCBI/Uniprot data below describe general gene information for BMPR2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001195.2
[Other Products]
NCBI GenBank Nucleotide #
NM_001204.6
[Other Products]
UniProt Primary Accession #
Q13873
[Other Products]
UniProt Secondary Accession #
Q16569; Q4ZG08; Q53SA5; Q585T8[Other Products]
UniProt Related Accession #
Q13873[Other Products]
NCBI Official Full Name
bone morphogenetic protein receptor type-2
NCBI Official Synonym Full Names
bone morphogenetic protein receptor, type II (serine/threonine kinase)
NCBI Official Symbol
BMPR2??[Similar Products]
NCBI Official Synonym Symbols
BMR2; PPH1; BMPR3; BRK-3; T-ALK; BMPR-II
??[Similar Products]
NCBI Protein Information
bone morphogenetic protein receptor type-2; BMPR-2; BMP type-2 receptor; BMP type II receptor; type II activin receptor-like kinase; bone morphogenetic protein receptor type II; type II receptor for bone morphogenetic protein-4
UniProt Protein Name
Bone morphogenetic protein receptor type-2
UniProt Synonym Protein Names
Bone morphogenetic protein receptor type II
Protein Family
Bone morphogenetic protein receptor
UniProt Gene Name
BMPR2??[Similar Products]
UniProt Synonym Gene Names
PPH1; BMP type-2 receptor; BMPR-2; BMP type II receptor; BMPR-II??[Similar Products]
UniProt Entry Name
BMPR2_HUMAN
NCBI Summary for BMPR2
This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, Jul 2008]
UniProt Comments for BMPR2
BMPR2: a serine/threonine-protein kinase receptor for bone morphogenetic protein (BMP). Binds to BMP-7, BMP-2 and, less efficiently, BMP-4. Binding is weak but enhanced by the presence of type I receptors for BMPs. On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Defects in BMPR2 are the cause of primary pulmonary hypertension (PPH1), a weakly penetrant dominant disorder, associated with lesions in pulmonary arterioles, elevated pulmonary arterial pressure, and right ventricular failure.
Protein type: Membrane protein, integral; Kinase, protein; Protein kinase, TKL; Cell cycle regulation; EC 2.7.11.30; Protein kinase, Ser/Thr (receptor); TKL group; STKR family; Type2 subfamily
Chromosomal Location of Human Ortholog: 2q33-q34
Cellular Component: extracellular space; cell surface; cell soma; integral to plasma membrane; cytoplasm; apical plasma membrane; dendrite; basal plasma membrane; plasma membrane; caveola
Molecular Function: transforming growth factor beta receptor activity; protein binding; metal ion binding; growth factor binding; activin receptor activity, type II; ATP binding; receptor signaling protein serine/threonine kinase activity
Biological Process: limb development; transcription from RNA polymerase II promoter; regulation of lung blood pressure; activin receptor signaling pathway; protein amino acid phosphorylation; BMP signaling pathway; anterior/posterior pattern formation; proteoglycan biosynthetic process; transmembrane receptor protein serine/threonine kinase signaling pathway; lymphangiogenesis; positive regulation of BMP signaling pathway; negative regulation of systemic arterial blood pressure; chondrocyte development; positive regulation of bone mineralization; cellular response to starvation; negative regulation of vasoconstriction; regulation of cell proliferation; positive regulation of osteoblast differentiation; mesoderm formation; positive regulation of axon extension involved in axon guidance; blood vessel remodeling; positive regulation of endothelial cell proliferation; negative regulation of cell growth; brain development; vascular endothelial growth factor receptor signaling pathway; alveolus development
Disease: Pulmonary Venoocclusive Disease 1, Autosomal Dominant; Pulmonary Hypertension, Primary, 1
Research Articles on BMPR2
1. Simultaneous exposure of pulmonary smooth muscle cells to viral protein(s) and cocaine exacerbates downregulation of BMPR axis that may result in enhanced pulmonary vasculature aberrations in HIV positive drug users.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.